Gilead Sciences Net Non-Operating Interest Income Expense (Quarterly) Analysis

Gilead Sciences, Inc. (GILD)

124.31 -0.60 (-0.48%) USD | NASDAQ | Jan 20, 16:00

124.25 -0.06 (-0.05%) After-Hours: 20:00

View Net Non-Operating Interest Income Expense (Quarterly) for GILD.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Net Non-Operating Interest Income Expense (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Net Non-Operating Interest Income Expense (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Net Non-Operating Interest Income Expense (Quarterly) Benchmarks

Start Trial

Amgen, Inc.	Upgrade
Johnson & Johnson	Upgrade
Eli Lilly & Co.	Upgrade
Merck & Co., Inc.	Upgrade
Regeneron Pharmaceuticals, Inc.	Upgrade